why is tirzepatide going away What to Expect After Starting Injections Why You Might Tolerate One

Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors , which are all involved in regulating metabolism and energy use

If you're taking a GLP-1 medication, you can increase your dose once every 4 weeks as long as you're tolerating your dose and your side effects are manageable

Adults with obesity using the GLP-1 receptor agonist class drug known as PF-08653944 shed up to 12.3 percent of their body weight compared with a placebo drug after 28 weeks, the New York City-based drugmaker said in a statement

Additionally, those taking other medications that relax the lower esophageal sphinctersuch as anticholinergics or calcium channel blockersmay experience compounded reflux when adding Zepbound